Sze H - Search Results

1

Surveillance mammography after breast conservation therapy in Hong Kong: effectiveness and feasibility of risk-adapted approach.

Yau TK, Sze H, Soong IS, Wong W, Chan K, Chang A, Lau KY, Lee A. Yau TK, et al. Among authors: sze h. Breast. 2008 Apr;17(2):132-7. doi: 10.1016/j.breast.2007.08.001. Epub 2007 Oct 1. Breast. 2008. PMID: 17905584

2

Trends and patterns of breast conservation treatment in Hong Kong: 1994-2007.

Yau TK, Soong IS, Sze H, Choi CW, Yeung MW, Ng WT, Lee AW. Yau TK, et al. Among authors: sze h. Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):98-103. doi: 10.1016/j.ijrobp.2008.07.066. Epub 2008 Dec 26. Int J Radiat Oncol Biol Phys. 2009. PMID: 19101091

3

Should young age be a contra-indication to breast conservation treatment in Chinese women? Twelve-year experience from a public cancer centre in Hong Kong.

Yau TK, Choi CW, Sze H, Soong IS, Lee AW. Yau TK, et al. Among authors: sze h. Hong Kong Med J. 2009 Apr;15(2):94-9. Hong Kong Med J. 2009. PMID: 19342734 Free article.

4

Evaluation of the prognostic value of 2005 St Gallen risk categories for operated breast cancers in Hong Kong.

Yau TK, Soong IS, Chan K, Chang A, Sze H, Yeung MW, Tung R, Lau S, Lee A. Yau TK, et al. Among authors: sze h. Breast. 2008 Feb;17(1):58-63. doi: 10.1016/j.breast.2007.06.007. Epub 2007 Sep 4. Breast. 2008. PMID: 17804235

5

HER2 overexpression of breast cancers in Hong Kong: prevalence and concordance between immunohistochemistry and in-situ hybridisation assays.

Yau TK, Sze H, Soong IS, Hioe F, Khoo US, Lee AW. Yau TK, et al. Among authors: sze h. Hong Kong Med J. 2008 Apr;14(2):130-5. Hong Kong Med J. 2008. PMID: 18382020 Free article.

6

The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement.

Lee AWM, Ng WT, Chan LK, Chan OSH, Hung WM, Chan CC, Cheng PTC, Sze H, Lam TS, Yau TK. Lee AWM, et al. Among authors: sze h. Oral Oncol. 2012 Oct;48(10):1007-1013. doi: 10.1016/j.oraloncology.2012.03.022. Epub 2012 Apr 22. Oral Oncol. 2012. PMID: 22525607

7

A tale of two cities in China: Hong Kong and Shenzhen.

Lee AW, Sze H, Lam KO, Chen X. Lee AW, et al. Among authors: sze h. Int J Radiat Oncol Biol Phys. 2014 Jul 15;89(4):704-8. doi: 10.1016/j.ijrobp.2013.12.053. Int J Radiat Oncol Biol Phys. 2014. PMID: 24969788 No abstract available.

8

Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?

Sze H, Chan LL, Ng WT, Hung AW, Lee MC, Chang AT, Chan OS, Cheung FY, Yeung RM, Lee AW. Sze H, et al. Oral Oncol. 2014 Dec;50(12):1188-95. doi: 10.1016/j.oraloncology.2014.09.001. Epub 2014 Sep 30. Oral Oncol. 2014. PMID: 25261296

9

Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology 2019.

Poon DM, Chan CK, Chan K, Chu WH, Kwong PW, Lam W, Law KS, Lee EK, Liu PL, Sze HC, Wong JH, Chan ES. Poon DM, et al. Among authors: sze hc. Asia Pac J Clin Oncol. 2021 Apr;17 Suppl 3:27-38. doi: 10.1111/ajco.13581. Asia Pac J Clin Oncol. 2021. PMID: 33860644

10

Abiraterone acetate in metastatic castration-resistant prostate cancer - the unanticipated real-world clinical experience.

Poon DM, Chan K, Lee SH, Chan TW, Sze H, Lee EK, Lam D, Chan MF. Poon DM, et al. Among authors: sze h. BMC Urol. 2016 Mar 22;16:12. doi: 10.1186/s12894-016-0132-z. BMC Urol. 2016. PMID: 27001043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters